Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment

Eye

Volumn 23, Issue 5, 2009, Pages 1238-1239

  Krishnan, R ^a   Goverdhan, S ^a   Lochhead, J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEGAPTANIB;

ADULT; CASE REPORT; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; HUMAN; INFORMED CONSENT; LASER COAGULATION; LETTER; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA NEOVASCULARIZATION; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; APTAMERS, NUCLEOTIDE; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MIDDLE AGED; RETINAL DETACHMENT; VISUAL ACUITY;

EID: 65949123351     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.179     Document Type: Letter

References (3)

1. Adamis AP, Altaweel M, Bressler NM, Cunningham Jr ET, Davis MD, Goldbaum M et al. Macugen Diabetic Retinopathy Study Group. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006; 113: 23-28.
2. Arevalo JF, Maia M, Flynn Jr H, Saravia M, Avery RL, Wu L et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin(R)) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008; 92: 213-216.
3. Tranos P, Gemenetzi M, Papandroudis A, Chrisafis C, Papadakos D. Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Eye 2007; (e-pub ahead of print).